Drugs for HER-2-positive breast cancer

Growth factor receptors have long been known to drive malignant transformation and cancer progression. The epidermal growth factor receptor (EGFR, ErbB, HER) system is likely the best described membrane receptor tyrosine kinase family in malignant tumors. With implementation of the growth-inhibitory...

Full description

Bibliographic Details

Published in:	Springer eBooks.
Corporate Author:	SpringerLink (Online service)
Other Authors:	Sibilia, Maria, Zielinski, Christoph C., Bartsch, Rupert, Grunt, Thomas W.
Format:	Electronic Resource
Language:	English
Published:	Basel Springer Basel c2011.
Subjects:	Medicine. Oncology. Immunology. Electronic books.
Online Access:	Available for University of the Philippines Diliman via SpringerLink. Click here to access